
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies
|
|||||
![]() The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies ![]() The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges. . . . → Read More: Infographic – Countries Making Covid-19 Vaccines ![]() Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply ![]() A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy ![]() A promising solution for vaccine distribution is staring policy-makers in the face, on street corners and shopping centers across the U.S., retail chain stores. . . . → Read More: Essay – Enlist U.S. Retailers for Vaccine Distribution ![]() A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant ![]() A new challenge competition from XPrize is looking for alternatives to chicken and fish that look and taste like the real thing, but are friendlier to the planet. . . . → Read More: Challenge Seeks Sustainable Chicken, Fish Alternatives ![]() A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway ![]() Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal ![]() A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |